CorRen Medical

CorRen Medical leverages its AI-driven, multi-element ultrasound technology to advance the early diagnosis of Peripheral Artery Disease (PAD) through accessible, user-friendly, and reimbursable Ankle Brachial Index (ABI) testing for hospitals, outpatient centers, and specialty clinics. Its UltraSense platform offers superior accuracy and ease of use, eliminating the need for certified technicians and significantly reducing testing time compared to traditional methods. The technology automates PAD diagnosis, cutting testing time by 70% – providing a cost-effective and scalable solution.